{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T04:24:33Z","timestamp":1750739073463,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000238","name":"Brain Tumour Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10633-019-09703-9","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T17:09:18Z","timestamp":1561568958000},"page":"137-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Central and peripheral steady-state visual evoked potentials in children with optic pathway gliomas"],"prefix":"10.1007","volume":"139","author":[{"given":"Sarah Zakaib","family":"Rassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis H.","family":"Ospina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Bochereau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvan","family":"Samson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8680-1615","authenticated-orcid":false,"given":"Dave","family":"Saint-Amour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,26]]},"reference":[{"issue":"11","key":"9703_CR1","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/neuonc\/not120","volume":"15","author":"JP Kelly","year":"2013","unstructured":"Kelly JP, Weiss AH (2013) Detection of tumor progression in optic pathway glioma with and without neurofibromatosis type 1. Neuro-oncology 15(11):1560\u20131567","journal-title":"Neuro-oncology"},{"issue":"4","key":"9703_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.pediatrneurol.2005.06.013","volume":"34","author":"A Ammendola","year":"2006","unstructured":"Ammendola A, Ciccone G, Ammendola E (2006) Utility of multimodal evoked potentials study in neurofibromatosis type 1 of childhood. Pediatr Neurol 34(4):276\u2013280","journal-title":"Pediatr Neurol"},{"issue":"5","key":"9703_CR3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/pbc.20655","volume":"46","author":"CD Jahraus","year":"2006","unstructured":"Jahraus CD, Tarbell NJ (2006) Optic pathway gliomas. Pediatr Blood Cancer 46(5):586\u2013596","journal-title":"Pediatr Blood Cancer"},{"key":"9703_CR4","unstructured":"World Health Organisation (2017) Cancer fact sheet"},{"issue":"21 supplement 1","key":"9703_CR5","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1212\/01.wnl.0000435745.95155.b8","volume":"81","author":"MJ Fisher","year":"2013","unstructured":"Fisher MJ et al (2013) Functional outcome measures for NF1-associated optic pathway glioma clinical trials. Neurology 81(21 supplement 1):S15\u2013S24","journal-title":"Neurology"},{"issue":"3","key":"9703_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/WNO.0b013e31822aef82","volume":"31","author":"RA Avery","year":"2011","unstructured":"Avery RA, Fisher MJ, Liu GT (2011) Optic pathway gliomas. J Neuroophthalmol 31(3):269\u2013278","journal-title":"J Neuroophthalmol"},{"key":"9703_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pediatrneurol.2017.06.019","volume":"75","author":"V Robert-Boire","year":"2017","unstructured":"Robert-Boire V et al (2017) Clinical presentation and outcome of patients with optic pathway glioma. Pediatr Neurol 75:55\u201360","journal-title":"Pediatr Neurol"},{"issue":"11","key":"9703_CR8","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00381-015-2855-7","volume":"31","author":"K Aquilina","year":"2015","unstructured":"Aquilina K et al (2015) Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions? Child Nerv Syst 31(11):2041\u20132049","journal-title":"Child Nerv Syst"},{"issue":"3","key":"9703_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ana.21107","volume":"61","author":"R Listernick","year":"2007","unstructured":"Listernick R et al (2007) Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61(3):189\u2013198","journal-title":"Ann Neurol"},{"issue":"3","key":"9703_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10633-013-9399-5","volume":"127","author":"C Van Mierlo","year":"2013","unstructured":"Van Mierlo C et al (2013) Role of visual evoked potentials in the assessment and management of optic pathway gliomas in children. Doc Ophthalmol 127(3):177\u2013190","journal-title":"Doc Ophthalmol"},{"issue":"5","key":"9703_CR11","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/FOC-07\/11\/E2","volume":"23","author":"MJ Binning","year":"2007","unstructured":"Binning MJ et al (2007) Optic pathway gliomas: a review. Neurosurg Focus 23(5):E2","journal-title":"Neurosurg Focus"},{"issue":"4","key":"9703_CR12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0002-9394(00)00852-7","volume":"131","author":"LJ Balcer","year":"2001","unstructured":"Balcer LJ et al (2001) Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Am J Ophthalmol 131(4):442\u2013445","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"9703_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10633-018-9635-0","volume":"136","author":"P de Freitas Dotto","year":"2018","unstructured":"de Freitas Dotto P et al (2018) Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1. Doc Ophthalmol 136(3):177\u2013189","journal-title":"Doc Ophthalmol"},{"issue":"9","key":"9703_CR14","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S1474-4422(10)70181-2","volume":"9","author":"FG Dhermain","year":"2010","unstructured":"Dhermain FG et al (2010) Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas. Lancet Neurol 9(9):906\u2013920","journal-title":"Lancet Neurol"},{"issue":"5","key":"9703_CR15","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.ajo.2015.07.036","volume":"160","author":"RA Avery","year":"2015","unstructured":"Avery RA et al (2015) Longitudinal change of circumpapillary retinal nerve fiber layer thickness in children with optic pathway gliomas. Am J Ophthalmol 160(5):944\u2013952.e1","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"9703_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/pbc.24726","volume":"61","author":"E Kalin-Hajdu","year":"2014","unstructured":"Kalin-Hajdu E et al (2014) Visual acuity of children treated with chemotherapy for optic pathway gliomas. Pediatr Blood Cancer 61(2):223\u2013227","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"9703_CR17","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1167\/iovs.03-0602","volume":"45","author":"DC Hood","year":"2004","unstructured":"Hood DC et al (2004) Detecting early to mild glaucomatous damage: a comparison of the multifocal VEP and automated perimetry. Invest Ophthalmol Vis Sci 45(2):492\u2013498","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"9703_CR18","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1167\/iovs.06-0561","volume":"48","author":"B Fortune","year":"2007","unstructured":"Fortune B et al (2007) Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma. Invest Ophthalmol Vis Sci 48(3):1173\u20131180","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"9703_CR19","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1212\/WNL.58.8.1261","volume":"58","author":"G Harding","year":"2002","unstructured":"Harding G et al (2002) Field-specific visual-evoked potentials identifying field defects in vigabatrin-treated children. Neurology 58(8):1261\u20131265","journal-title":"Neurology"},{"key":"9703_CR20","unstructured":"Colenbrander A (2002) Visual standards aspects and ranges of vision loss with emphasis on population surveys. Report prepared for the International Council of Ophthalmology at the 29th International Congress of Ophthalmology, Sydney, Australia"},{"issue":"6","key":"9703_CR21","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1001\/archopht.1991.01080060080030","volume":"109","author":"JC Horton","year":"1991","unstructured":"Horton JC, Hoyt WF (1991) The representation of the visual field in human striate cortex. A revision of the classic Holmes map. Arch Ophthalmol 109(6):816\u2013824","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"9703_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/15.6.4","volume":"15","author":"AM Norcia","year":"2015","unstructured":"Norcia AM et al (2015) The steady-state visual evoked potential in vision research: a review. J Vis 15(6):4","journal-title":"J Vis"},{"issue":"2","key":"9703_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10633-013-9387-9","volume":"127","author":"CS Matsumoto","year":"2013","unstructured":"Matsumoto CS et al (2013) Liquid crystal display screens as stimulators for visually evoked potentials: flash effect due to delay in luminance changes. Doc Ophthalmol 127(2):103\u2013112","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"9703_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00006324-199601000-00008","volume":"73","author":"M Bach","year":"1996","unstructured":"Bach M (1996) The Freiburg Visual Acuity test\u2014automatic measurement of visual acuity. Optom Vis Sci 73(1):49\u201353","journal-title":"Optom Vis Sci"},{"key":"9703_CR25","first-page":"371","volume":"10","author":"HH Jasper","year":"1958","unstructured":"Jasper HH (1958) The ten twenty electrode system of the international federation. Electroencephalogr Clin Neurophysiol 10:371\u2013375","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"1","key":"9703_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1023\/A:1002648202420","volume":"99","author":"M Bach","year":"1999","unstructured":"Bach M, Meigen T (1999) Do\u2019s and don\u2019ts in Fourier analysis of steady-state potentials. Doc Ophthalmol 99(1):69\u201382","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"9703_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1023\/A:1002097208337","volume":"98","author":"T Meigen","year":"1999","unstructured":"Meigen T, Bach M (1999) On the statistical significance of electrophysiological steady-state responses. Doc Ophthalmol 98(3):207\u2013232","journal-title":"Doc Ophthalmol"},{"issue":"2","key":"9703_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jcrs.2004.01.014","volume":"30","author":"JT Holladay","year":"2004","unstructured":"Holladay JT (2004) Visual acuity measurements. J Cataract Refract Surg 30(2):287\u2013290","journal-title":"J Cataract Refract Surg"},{"issue":"9","key":"9703_CR29","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.clinph.2012.02.067","volume":"123","author":"S Abdullah","year":"2012","unstructured":"Abdullah S, Boon M, Maddess T (2012) Contrast-response functions of the multifocal steady-state VEP (MSV). Clin Neurophysiol 123(9):1865\u20131871","journal-title":"Clin Neurophysiol"},{"issue":"7","key":"9703_CR30","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/hbm.21324","volume":"33","author":"J Wu","year":"2012","unstructured":"Wu J et al (2012) Retinotopic mapping of the peripheral visual field to human visual cortex by functional magnetic resonance imaging. Hum Brain Mapp 33(7):1727\u20131740","journal-title":"Hum Brain Mapp"},{"issue":"4","key":"9703_CR31","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jaapos.2006.02.003","volume":"10","author":"JP Kelly","year":"2006","unstructured":"Kelly JP, Weiss AH (2006) Comparison of pattern visual-evoked potentials to perimetry in the detection of visual loss in children with optic pathway gliomas. J AAPOS 10(4):298\u2013306","journal-title":"J AAPOS"},{"issue":"4","key":"9703_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jaapos.2006.02.004","volume":"10","author":"DH Wolsey","year":"2006","unstructured":"Wolsey DH et al (2006) Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? J AAPOS 10(4):307\u2013311","journal-title":"J AAPOS"},{"issue":"4","key":"9703_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jaapos.2006.06.002","volume":"10","author":"RM Siatkowski","year":"2006","unstructured":"Siatkowski RM (2006) VEP testing and visual pathway gliomas: not quite ready for prime time. J AAPOS 10(4):293\u2013295","journal-title":"J AAPOS"},{"key":"9703_CR34","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1097\/WNO.0000000000000550","volume":"37","author":"PM de Blank","year":"2017","unstructured":"de Blank PM et al (2017) Optic pathway gliomas in neurofibromatosis type 1: an update: surveillance, treatment indications, and biomarkers of vision. J Neuroophthalmol 37:S23\u2013S32","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"9703_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11060-008-9537-1","volume":"88","author":"B Falsini","year":"2008","unstructured":"Falsini B et al (2008) Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings. J Neurooncol 88(1):87\u201396","journal-title":"J Neurooncol"},{"issue":"1","key":"9703_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S1388-2457(03)00282-7","volume":"115","author":"MTS Trisciuzzi","year":"2004","unstructured":"Trisciuzzi MTS et al (2004) A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas. Clin Neurophysiol 115(1):217\u2013226","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"9703_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10633-014-9439-9","volume":"129","author":"N H\u00e9bert-Lalonde","year":"2014","unstructured":"H\u00e9bert-Lalonde N et al (2014) A frequency-tagging electrophysiological method to identify central and peripheral visual field deficits. Doc Ophthalmol 129(1):17\u201326","journal-title":"Doc Ophthalmol"},{"key":"9703_CR38","first-page":"71","volume":"104","author":"DC Hood","year":"2006","unstructured":"Hood DC et al (2006) The role of the multifocal visual evoked potential (mfVEP) latency in understanding optic nerve and retinal diseases. Trans Am Ophthalmol Soc 104:71","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"6","key":"9703_CR39","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1055\/s-2008-1073043","volume":"25","author":"C Kuenzle","year":"1994","unstructured":"Kuenzle C et al (1994) Follow-up of optic pathway gliomas in children with neurofibromatosis type 1. Neuropediatrics 25(6):295\u2013300","journal-title":"Neuropediatrics"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-019-09703-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10633-019-09703-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-019-09703-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T23:21:28Z","timestamp":1593040888000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10633-019-09703-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,26]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["9703"],"URL":"https:\/\/doi.org\/10.1007\/s10633-019-09703-9","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"type":"print","value":"0012-4486"},{"type":"electronic","value":"1573-2622"}],"subject":[],"published":{"date-parts":[[2019,6,26]]},"assertion":[{"value":"6 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human rights"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the welfare of animals"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}